Asterand functional genomics, admet, supply/service news

The board of the tools and tissue-based research services company extended to Jan. 17 the deadline for submissions of potential offers to acquire all or part of the business. The extension, which will allow potential acquirers about two more weeks for due diligence, was given due to limited time before the Christmas break. The board's timeline includes a mid-February deadline for a formal sales announcement. Covington Associates and Daniel Stewart are advising Asterand. The company previously extended the time period to early 2012 to allow more time for due diligence after a revised cash position showed the company has sufficient cash to fund operations through early 2012 (see BioCentury, Dec. 5, 2011). ...